API Product

Vilanterol Trifenatate

vilanterol-trifenatate
Product Status:
Under Development
Available Grades:
  • Dev.
Regulatory Status:
Under Development
Product Type:
  • LABA
CAS Number:
503070-58-4
Modes of Application:
  • Inhalation
  • Nasal
Common Indications:
  • Asthma
  • COPD
Last Inspection:
FDA May 2018

Vilanterol Trifenatate for development trials with customized Particle Design, resulting in Inhalation grade material with highly customizable PSD to befit your application.

Our technology and expertise range yields unmatched impurity profiles with highly reproducibility between batches, resulting in a superior API.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Fluticasone FuroateGlycopyrronium Bromide or Umeclidinium Bromide.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (84.51 KB)
Download